Literature DB >> 35361895

T-DXd improves PFS versus T-DM1.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35361895     DOI： 10.1038/s41571-022-00629-x

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Authors:  Javier Cortés; Sung-Bae Kim; Wei-Pang Chung; Seock-Ah Im; Yeon Hee Park; Roberto Hegg; Min Hwan Kim; Ling-Ming Tseng; Vanessa Petry; Chi-Feng Chung; Hiroji Iwata; Erika Hamilton; Giuseppe Curigliano; Binghe Xu; Chiun-Sheng Huang; Jee Hyun Kim; Joanne W Y Chiu; Jose Luiz Pedrini; Caleb Lee; Yali Liu; Jillian Cathcart; Emarjola Bako; Sunil Verma; Sara A Hurvitz
Journal:  N Engl J Med       Date:  2022-03-24       Impact factor: 176.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.